MedTrace Logo

Active-Controlled Study to Assess the Efficacy and Safety of DFD-05 in Subjects With Common Warts

NCT02798419 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2016-08-16

No results posted yet for this study

Summary

DFD05 vs. Active01 in the treatment of common warts

Conditions

  • Common Warts

Interventions

DRUG

DFD05 Cream

DRUG

Active01 Cream

Sponsors & Collaborators

  • Dr. Reddys Laboratories, SA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-05-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798419 on ClinicalTrials.gov